- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05525624
Transition Model-Based Discharge Training in Parents of Preterm Infants (TRAMPRE)
August 31, 2022 updated by: Serife Tutar, Suleyman Demirel University
Evaluation of the Effectiveness of Transition Model-Based Discharge Training in Parents of Preterm Infants:Double Blinded A Randomized Controlled Study
Infant and Child Monitoring Protocol prepared by the General Directorate of Mother and Child Health and Family Planning of the Ministry of Health regarding the monitoring of postpartum processes in our country.
However, there is no separate recommendation for home follow-up and care of mothers and babies who gave birth preterm.
In addition, there are deficiencies in the effective conduct of home visits specified in these guides.
In addition to the parents' lack of knowledge about the long-term follow-up and care of these babies, the coordination between primary and secondary health care providers and senior health care providers is not at the desired level.
In addition to all these, services such as training and consultancy cannot be carried out due to disruptions in many polyclinic services due to the COVID-19 pandemic worldwide.
For this reason, there is a need to develop programs for home care and follow-up of preterm infants, who are a sensitive population, in terms of both reducing the patient density in hospitals and reducing the hospital return rates of preterm infants.
In this context, the aim of our research is; The aim of this study is to evaluate the effectiveness of discharge training based on the Transition Model in parents with preterm infants.H1: In the group in which the interventions based on the Transition Model are applied, the information needs of the parents will be met more compared to the control group.
H1: Parent-infant role development will be higher in the group in which interventions based on the Transition Model are applied.
H1: The level of coping with stress will be better in the group in which interventions based on the Transition Model are applied.
H1: The level of grief will be lower in the group in which interventions based on the Transition Model are applied.
H1: The level of postpartum depression will be lower in the group in which interventions based on the Transition Model are applied.
H1: Babies in the group in which interventions based on the Transition Model are applied will have fewer hospital admissions, except for the planned outpatient visit
Study Overview
Status
Completed
Intervention / Treatment
Detailed Description
Intervention Group: The intervention protocol of the research will be based on the Transition Model.
Discharge training will be applied to the participants in line with the "Preterm Baby Care Guide" at the discharge stage.
Weekly telephone follow-up will be carried out for 12 weeks after discharge.
Applications to be made to the initiative group are given below.
Phone Follow-up/Interview: During the first 12 weeks following the discharge of the preterm baby, parents will be interviewed by phone at least once a week.
During the interview, issues concerning the baby's health status (baby bed, physical conditions of the house, newborn jaundice, nutrition, etc.) will be included in the scope of the interview and suggestions will be made for the baby's growth and development in healthy conditions (safe sleep, clothing selection, etc.).
Interviews will be held in line with the "Baby Care Skill Form" and each interview will be recorded in the form.
The duration and number of interviews will be determined according to the needs of the parent.
In addition, in this process, information such as which health institution application has been made, the degree of the institution applied (primary / secondary / tertiary health institution) will be recorded.
Control Group: Participants in this group will be included in the routine neonatal clinic discharge training of the hospital where the research was conducted and no intervention will be applied.
The Parents and Preterm Baby General Information Form will be applied to the parents who agreed to participate in the study at the first interview, and when the data collection process of the research is completed, these parents will be contacted by phone and the Transition Scale and Edinburgh Postnatal Depression Scale will be applied.
As in the intervention group, information such as the status of application to the health institution, the reason for the application and the degree of the institution applied to (primary / secondary / tertiary health institution) will be recorded in this group.
Statistical Package of Social Science (SPSS 23) package program will be used in the evaluation of the data obtained from the research.
For the intervention and control groups, the Cronbach Alpha coefficient, scale score average and minimum-maximum values will be calculated for the pre-test and post-test.
In order to compare the pre-test and post-test data of the intervention and control groups, the t-test for the difference of the mean of the two peer groups (t-test of two paired groups), the Wilcoxon Signed Ranks Test, and the Wilcoxon Signed Ranks Test, and the Mann Whitney-U Test for the data without normal distribution will be performed.
Study Type
Interventional
Enrollment (Actual)
200
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Isparta, Turkey, 32000
- Suleyman Demirel University
-
Isparta, Turkey, 32000
- Şerife Tutar
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
11 years to 45 years (Child, Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Description
Inclusion Criteria:
For mothers;
- Having given birth between 340/7-366/7 weeks
- Absence of a chronic disease that may affect physical and mental care
- Residing within the provincial borders of Antalya
For babies;
- No congenital anomalies
- Postpartum neonatal asphyxia, respiratory distress syndrome, intraventricular hemorrhage and necrotizing enterocolitis etc. no problem
- Postpartum Apgar score >7 Babies discharged after being followed up in
- The neonatal clinic will be included in the study
Exclusion Criteria:
For mothers;
*Having a physical or mental chronic illness that may affect the baby's care process
For babies;
- Neonatal asphyxia, respiratory distress syndrome, intraventricular hemorrhage and necrotizing enterocolitis etc. receiving ventilator support after delivery.
- Babies with a problem will not be included in the study.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Experimental
TRAMPRE is an acronym that defines multimodal interventions discharge training.
TRAMPRE will be applied to the participants in line with the "Preterm Baby Care Guide" at the discharge stage.
Weekly telephone follow-up will be carried out for 12 weeks after discharge.
Applications to be made to the initiative group are given below.
Phone Follow-up/Interview: During the first 12 weeks following the discharge of the preterm baby, parents will be interviewed by phone at least once a week.
|
discharge interventions Transition Model is discharge interventions in parents of preterm infants.
Other Names:
|
|
Active Comparator: Control Group
Participants in this group will be included in the routine neonatal clinic discharge training of the hospital where the research was conducted and no intervention will be applied.
|
routine neonatal clinic discharge training of the hospital
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Effect of TRAMPRE
Time Frame: Change from baseline effect of TRAMPRE at 3 months
|
TRAMPRE will be applied to the participants in line with the "Preterm Baby Care Guide" at the discharge stage.
Weekly telephone follow-up will be carried out for 12 weeks after discharge.
Applications to be made to the initiative group are given below.
Phone Follow-up/Interview: During the first 12 weeks following the discharge of the preterm baby, parents will be interviewed by phone at least once a week.
|
Change from baseline effect of TRAMPRE at 3 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Level of postpartum depression
Time Frame: Change from baseline level of postpartum depression at 3 months
|
The Edinburgh Postpartum Depression Scale will be administered three months after discharge.
|
Change from baseline level of postpartum depression at 3 months
|
|
Frequency of readmission
Time Frame: Change from baseline Frequency of readmission at 3 months
|
Planned/unplanned admission to hospital after discharge:It is planned to be used in weekly planned parent interviews after discharge.
The content of the form includes questions about hospital applications after discharge and the reasons for application.
|
Change from baseline Frequency of readmission at 3 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Şerife Tutar, Suleyman Demirel University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 5, 2021
Primary Completion (Actual)
June 30, 2022
Study Completion (Actual)
July 31, 2022
Study Registration Dates
First Submitted
February 27, 2022
First Submitted That Met QC Criteria
August 31, 2022
First Posted (Actual)
September 1, 2022
Study Record Updates
Last Update Posted (Actual)
September 1, 2022
Last Update Submitted That Met QC Criteria
August 31, 2022
Last Verified
April 1, 2022
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 0732
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Premature Birth
-
Shaare Zedek Medical CenterTerminatedPremature Birth of NewbornIsrael
-
University of VirginiaCompletedPremature Birth of NewbornUnited States
-
Case Western Reserve UniversityCompleted
-
University of California, San FranciscoUniversity of California, San Diego; University of California, Los Angeles; Kaiser...CompletedPremature Birth of NewbornUnited States
-
Universidad Complutense de MadridCompletedPremature Birth of Newborn
-
Indiana UniversityCompletedPremature LaborUnited States
-
Washington University School of MedicineUniversity of Southern CaliforniaCompletedPremature Birth of NewbornUnited States
-
University of ArkansasCompletedPremature Birth of NewbornUnited States
-
Elgan Pharma Ltd.Terminated
-
Hôpital de la Croix-RousseUnknownPremature Birth of NewbornFrance